DARE Reclassifies Matz from Class II to III, Reappoints Him, Sets 2026 Election; No Changes to Committee Assignments
Dare Bioscience, Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $2.19
Post-detection moves
1h
—
1d
—
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS